Details for New Drug Application (NDA): 008392
✉ Email this page to a colleague
NDA 008392 describes NYDRAZID, which is a drug marketed by Sandoz and Bristol Myers Squibb and is included in two NDAs. Additional details are available on the NYDRAZID profile page.
The generic ingredient in NYDRAZID is isoniazid. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
The generic ingredient in NYDRAZID is isoniazid. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
Summary for 008392
| Tradename: | NYDRAZID |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | isoniazid |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 008392
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
